James N. Woody

Insider Reports History

Entity
Individual
Location
C/O Oncomed Pharmaceuticals, Inc., 800 Chesapeake Drive, Redwood City, CA
Signature
/s/ James N. Woody
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James N. Woody:

Stock Role Class Num Shares Value Price $ Report Date Ownership
180 Life Sciences Corp. Chief Executive Officer, Director Common Stock 66.9K $12.6K $0.19 Dec 15, 2023 Direct
180 Life Sciences Corp. Chief Executive Officer, Director Stock Option (Right to Buy) 75K Sep 4, 2023 Direct

Insider Reports Filed by James N. Woody

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ATNF 180 Life Sciences Corp. Dec 15, 2023 1 $4.7K 4 Dec 18, 2023 Chief Executive Officer, Director
ATNF 180 Life Sciences Corp. Sep 4, 2023 1 $0 4 Sep 8, 2023 Chief Executive Officer, Director
ATNF 180 Life Sciences Corp. May 18, 2023 1 $41.2K 4 May 18, 2023 Chief Executive Officer, Director
ATNF 180 Life Sciences Corp. Dec 9, 2021 1 $53.4K 4 Dec 10, 2021 Chief Executive Officer, Director